The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization
- Conditions
- Coronary Artery DiseaseChest Pain
- Registration Number
- NCT00644657
- Lead Sponsor
- University of Oklahoma
- Brief Summary
This study will explore the effect of clopidogrel on coated-platelets in patients who are given a loading dose before diagnostic catheterization or percutaneous coronary intervention. We hypothesis that clopidogrel will reduce the percentage of platelets that are coated and therefore more hypercoagulable.
- Detailed Description
Platelet activity will be determined by light transmission aggregometry at baseline, after a 300 mg dose of clopidogrel and after the catheterization and/or angioplasty procedure. The change in the percentage of platelets that are coated platelets will be determined.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 27
- Patients given clopidogrel loading dose before scheduled catheterization or percutaneous intervention
- Acute coronary syndrome
- Unable to tolerate clopidogrel
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method The Percentage of Coated Platelets After the Administration of Clopidogrel in Patients Undergoing Cardiac Catheterization and/or Angioplasty 24 hours after the administration of clopidotrel The percentage of platelets that are collagen coated after the administration of clopidogrel.
- Secondary Outcome Measures
Name Time Method The Percentage of Coated Platelets After Coronary Angiography and/or PCI 6 hrs after procedure The percentage of coated platelets 24 hours after coronary angiography and/or PCI
Trial Locations
- Locations (1)
VA Medical Center, 1F187
🇺🇸Oklahoma City, Oklahoma, United States